Romano G, Tilly-Kiesi M K, Patti L, Taskinen M R, Pacioni D, Cassader M, Riccardi G, Rivellese A A
Department of Clinical and Experimental Medicine, Federico II University Medical School, Naples, Italy.
Diabetologia. 1998 Feb;41(2):193-200. doi: 10.1007/s001250050889.
To compare the effects of dietary cholesterol supplementation in insulin-dependent diabetic (IDDM) patients and normal subjects, 10 male IDDM patients in good glycaemic control (HbA1c 7.3+/-0.9%) (mean+/-SD) and normal plasma lipid levels, and 11 control male subjects of similar age, body mass index and lipid plasma levels underwent a double blind, cross-over, sequential study. Cholesterol supplementation of 800 mg/day or placebo were given for consecutive periods of 3 weeks. The concentration of plasma total cholesterol increased significantly with the dietary cholesterol supplementation compared to placebo in IDDM patients by 6% (p < 0.05) and in control subjects by 9% (p < 0.05). No changes were observed in the concentration of plasma triglycerides in either group. The LDL cholesterol level increased by 12% (p < 0.01) in patients and by 7% (p < 0.05) in control subjects. In patients plasma HDL cholesterol concentration remained the same, while in control subjects it tended to increase after cholesterol supplementation (from 1.14+/-0.26 to 1.23+/-0.27 mmol/l, p = 0.06). During the cholesterol intake period the mean concentration of LDL1, LDL2 and LDL3 subclasses in patients showed a significant increase by 21.0 (p < 0.05), 20.4 (p < 0.001) and 11.1% (p < 0.05), respectively, resulting in an 18.0% increase in mean total LDL mass (p < 0.001) without major changes in LDL composition. In the control subjects the changes in the concentrations of LDL subclasses during cholesterol intake were less and not significant. In the IDDM patients the cholesterol intake did not affect the concentration or composition of HDL subclasses or total HDL mass. In contrast, in control subjects cholesterol intake increased the mean concentration of HDL2a by 12.2.% (p < 0.05) and this increase was significantly different if compared to changes obtained in the patients. In conclusion, compared to normal subjects, in IDDM patients, dietary cholesterol intake increased the LDL particle mass significantly and had no positive effect on HDL.
为比较膳食补充胆固醇对胰岛素依赖型糖尿病(IDDM)患者和正常受试者的影响,10名血糖控制良好(糖化血红蛋白HbA1c为7.3±0.9%)(均值±标准差)且血脂水平正常的男性IDDM患者,以及11名年龄、体重指数和血脂水平相近的男性对照受试者进行了一项双盲、交叉、序贯研究。连续3周每天补充800毫克胆固醇或给予安慰剂。与安慰剂相比,IDDM患者膳食补充胆固醇后血浆总胆固醇浓度显著升高6%(p<0.05),对照受试者升高9%(p<0.05)。两组血浆甘油三酯浓度均未观察到变化。患者的低密度脂蛋白胆固醇水平升高12%(p<0.01),对照受试者升高7%(p<0.05)。患者血浆高密度脂蛋白胆固醇浓度保持不变,而对照受试者补充胆固醇后有升高趋势(从1.14±0.26升至1.23±0.27毫摩尔/升,p = 0.06)。在摄入胆固醇期间,患者中低密度脂蛋白1、低密度脂蛋白2和低密度脂蛋白3亚类的平均浓度分别显著升高21.0%(p<0.05)、20.4%(p<0.001)和11.1%(p<0.05),导致平均总低密度脂蛋白质量增加18.0%(p<0.001),低密度脂蛋白组成无重大变化。对照受试者在摄入胆固醇期间低密度脂蛋白亚类浓度变化较小且无显著性。在IDDM患者中,摄入胆固醇不影响高密度脂蛋白亚类的浓度或组成以及总高密度脂蛋白质量。相反,对照受试者摄入胆固醇后高密度脂蛋白2a的平均浓度升高12.2%(p<0.05),与患者的变化相比,这种升高有显著差异。总之,与正常受试者相比,IDDM患者膳食摄入胆固醇显著增加了低密度脂蛋白颗粒质量,对高密度脂蛋白无积极影响。